Membrane Bioreactors: Global Markets

Report Highlights

The global market for membrane bioreactors should grow from $2.5 billion in 2021 to $4.1 billion by 2026 with a compound annual growth rate (CAGR) of 10.5% for the period of 2021-2026.

Report Includes 

• 85 data tables and 45 additional tables
• An up-to-date review of the global market for membrane bioreactors (MBRs) within the industry
• Analyses of the global market trends, with data from 2020 and 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2026
• Evaluation and forecast the market size for membrane bioreactors, forecasted growth trends, and corresponding market share analysis by microbial process type, configuration, membrane type, application, and geographic region
• Highlights of the upcoming market potential for membrane bioreactors and areas of focus to forecast this market into various segments and sub-segments
• Country specific data and market value analysis for China, Japan, South Korea, Singapore, United States, Canada, Mexico, Germany, Spain, and the U.K.
• In-depth information (facts and figures) concerning the major factors influencing the progress of the market (benefits, and industry-specific challenges) with respect to specific growth trends, upcoming technologies, prospects, and contributions to the overall market
• Understanding of the membrane component of MBRs, the biological component, system configurations, typical MBR performance, cost analyses, system applications, and the filtration industry structure
• Review of patent grants for innovations relate to membrane bioreactor industry across each major category
• Assessment of the competitive developments such as joint ventures, mergers and acquisitions, new product development, expansions, and research and development activities in the global market for membrane bioreactor
• Company profiles of the leading global players, including Alfa Laval, SUEZ Water Technologies & Solutions, Evoqua Water Technologies, Asahi Kasei, Pentair and Mann+Hummel

Report Scope

This report covers the technological, economic, and business considerations of the membrane bioreactors market, with analyses and forecasts provided for global markets. Included in the report are descriptions of the market forces relevant to membrane bioreactors and their areas of application.

Global markets are presented by type of membrane bioreactor, and growth forecasts through 2026 are provided. Estimates on sales values are based on the prices in the supply chain at which the membrane bioreactors were procured by manufacturers.

Market-driving forces and industry structure are examined. International aspects are analyzed for all world regions and types of membrane bioreactors. Brief profiles of major global manufacturers are presented.

The presently developing COVID-19 pandemic has halted the progress of economies across the world for some time. But the world's economies are gradually reviving and have started ramping back up. In addition to taking measures to lock down their respective countries to contain the spread of the coronavirus, especially in affected cities, various governments across the world are also taking the measures necessary to contain the economic slowdown.

This report considers the impact of COVID-19. In 2020, the growth rate of every industry across the world was impacted by the pandemic, and the membrane bioreactors market was also indirectly affected. The market is, however, expected to bounce back in 2022, due to the relief packages or disaster aid packages provided by various governments to boost their economies.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

• Bioprocess Optimization and Digital Bio-manufacturing: Global Markets (BIO170B)
• Metal-organic Frameworks: Global Markets (AVM200B)
• Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets (PHM204C)
• Global DNA Sequencing: Research, Applied and Clinical Markets (BIO045J)
• Surgical Equipment: Technologies and Global Markets (HLC154C)